Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07461493

The Cancer Stage Shifting Initiative: Registry and Biorepository to Research and Address Health Disparities in Cancer Care

Status
Recruiting
Phase
Study type
Observational
Enrollment
100,000 (estimated)
Sponsor
National Minority Quality Forum · Academic / Other
Sex
All
Age
35 Years
Healthy volunteers
Accepted

Summary

The goal of this observational study is to establish a patient registry and a biorepository (sample collection and storage) to investigate health disparities, access, and barriers to cancer screening and early detection technologies. The registry and biorepository will serve as a resource to support Cancer Early Detection (CED) screenings and future research focused on communities at increased risk for cancer. The study seeks to address: •Barriers and disparities in cancer prevention, screening, and treatment, particularly in historically underrepresented populations. Participants will: * Attend a minimum of five clinic visits over a five-year period for scheduled annual assessments while actively enrolled in the study. * Complete questionnaires at each visit that collect information on their medical history, cancer history, and family cancer history. * Allow relevant health information from their electronic health records (EHR) to be collected and reviewed. * Provide blood, saliva, and stool samples for research purposes. * Enter a long-term follow-up period for an additional five years.

Conditions

Timeline

Start date
2025-03-11
Primary completion
2034-03-01
Completion
2039-03-01
First posted
2026-03-10
Last updated
2026-04-08

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT07461493. Inclusion in this directory is not an endorsement.

The Cancer Stage Shifting Initiative: Registry and Biorepository to Research and Address Health Disparities in Cancer Ca (NCT07461493) · Clinical Trials Directory